NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Orbits Oncology

Orbits Oncology

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.orbits-oncology.com/

Last Round

Accelerator

Feb 27, 2025

Total Funding Raised

$250,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Orbits Oncology is a biotechnology company that develops a cloud-based, AI-powered image analysis and drug screening platform designed to help cancer researchers make decisions in drug development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Precision Medicine, Medical AI, Medical Imaging, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

organoid analysisAI drug discoverypatient-derived organoidsPDOsphenotypic screeningcomputer visiondrug response analysislive-cell imaginglabel-free imagingprecision medicinecomputational biology3D cell culturecytotoxic analysistranslational medicinescientific SaaSIC50 calculationorgans-on-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Orbits Oncology Comparables

Compare Orbits Oncology with similar companies based on industry and business-model similarity.

Orbits Oncology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Orbits Oncology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorFeb 27, 2025
AcceleratorAug 6, 2024

Key People

Founding team and executive leadership

Tyler Gilcrest

Co-founder & COO

Founding Team

Abraham Lin

Chief Executive Officer

Executive Team

Orbits Oncology Investors

Notable investors and investment history

Orbits Oncology investors
InvestorRounds
AlphaLabAccelerator
Northpond VenturesAccelerator
McKesson VenturesAccelerator
Innovation WorksAccelerator
Merck Digital Sciences StudioAccelerator
New Jersey Innovation InstituteAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 17, 2026

    Monthly visitors increased 267% MoM.

  • Apr 18, 2026

    Monthly visitors grew 35% MoM.

Orbits Oncology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Orbits Oncology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Orbits Oncology's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range7
Year Founded2023
Last FundingFeb 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.